Amgen Inc. Property, Plant and Equipment, Other, Gross
Amgen Inc. (AMGN) had Property, Plant and Equipment, Other, Gross of $929.00 million as of 2022-12-31, per its 10-K filed 2023-02-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentOther · last filed 2023-02-09
- 2022-12-31: Property, Plant and Equipment, Other, Gross $929.00M.
- 2021-12-31: Property, Plant and Equipment, Other, Gross $862.00M.
- 2020-12-31: Property, Plant and Equipment, Other, Gross $1.09B.
- 2019-12-31: Property, Plant and Equipment, Other, Gross $975.00M; Property, Plant and Equipment, Other, Gross as first filed $3.31B.
| Period end | Property, Plant and Equipment, Other, Gross | Property, Plant and Equipment, Other, Gross as first filed |
|---|---|---|
| 2022-12-31 | $929.00M 10-K · filed 2023-02-09 | |
| 2021-12-31 | $862.00M 10-K · filed 2023-02-09 | |
| 2020-12-31 | $1.09B 10-K · filed 2022-02-16 | |
| 2019-12-31 | $975.00M 10-K · filed 2021-02-09 | $3.31B 10-K · filed 2020-02-12 |
| 2018-12-31 | $3.20B 10-K · filed 2020-02-12 | |
| 2017-12-31 | $3.25B 10-K · filed 2019-02-13 | $4.40B 10-K · filed 2018-02-13 |
| 2016-12-31 | $4.38B 10-K · filed 2018-02-13 | |
| 2015-12-31 | $4.28B 10-K · filed 2017-02-14 | |
| 2014-12-31 | $4.11B 8-K · filed 2016-10-31 | |
| 2013-12-31 | $4.11B 10-K · filed 2015-02-19 | |
| 2012-12-31 | $3.89B 10-K · filed 2014-02-24 | |
| 2011-12-31 | $3.75B 10-K · filed 2013-02-27 | |
| 2010-12-31 | $3.55B 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |